HALT_COVID-19 Natural history and laboratory tests for COVID-19 in South Africa

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:5 publications

Grant number: RIA2020EF-2928

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $594,930.98
  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Principle Investigator

    Pending
  • Research Location

    South Africa, Africa
  • Lead Research Institution

    Centre for the AIDS Programme of Research in South Africa
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The HALT_COVID-19 project (RIA2020EF-2928) aims to utilize a combination of approaches to characterise clinical disease progression and clinical outcomes among patients with SARS-CoV-2 viral infection and to perform a clinical evaluation of COVID-19 testing kits in South Africa.

Publicationslinked via Europe PMC

Last Updated:39 minutes ago

View all publications at Europe PMC

The Performance of Diagnostic Tests for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the South African Population: A Scoping Review.

Drug-Resistant TB, HIV and COVID-19 Co-Infection: Case Reviews from Kwa-Zulu Natal, South Africa.

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa.

Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa.

Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa.